Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?
| Autor: | Mark Kacar, S Denman, Sinisa Savic |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
Male medicine.medical_specialty Immunology mastocitoza udc:616-097 Omalizumab nonclonal mast cell activation syndrome postural orthostatic tachycardia syndrome Postural Orthostatic Tachycardia Syndrome Young Adult 03 medical and health sciences 0302 clinical medicine Internal medicine Anti-Allergic Agents medicine Humans Immunology and Allergy 030212 general & internal medicine mastocytosis posturalna ortostatska tahikardija business.industry 030228 respiratory system Underlying disease Concomitant Cardiology omalizumab business Mastocytosis neklonski sindrom aktivacije mastocitov medicine.drug |
| Zdroj: | Journal of investigational allergology & clinical immunology, vol. 28, no. 4, pp. 261-263, 2018. |
| ISSN: | 1018-9068 1698-0808 |
| DOI: | 10.18176/jiaci.0251 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|